Sari la continut
Sari la continut

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Barium chromate

EC / List no: 233-660-5 CAS no: 10294-40-3
Concern
Carcinogenic
Status
Concluded
Outcome
Appropriate to initiate regulatory risk management action
Follow-up
CLH
SVHC
Date of intention
05/03/2018
Date of RMOA conclusion
28/05/2019
RMOA conclusion document
Full RMOA document
Remarks
Authority
Netherlands
Submitter organisation
National Institute for Public Health and the Environment
Submitter email
bureau-reach@rivm.nl
Submitter phone
Submitter address
Co-submitter(s)
Latest update
08/07/2019

Categories Display


Route: .live2